Susruta (Suśruta)
c. 600 BCE · Indio (India antigua) · Cirugía
Antiguo cirujano indio tradicionalmente acreditado como autor del Sushruta Samhita, que contiene la discusión sistemática más antigua existente sobre la aplicación de la sanguijuela medicinal dentro de un texto quirúrgico.
Perfil
- Años de vida
- c. 600 BCE
- Nacionalidad
- Indian (Ancient)
- Época
- Antigua
- Campo principal
- Cirugía
Afiliaciones institucionales
- Ancient Indian medical tradition (Ayurveda) — exact institutional affiliation unknown
Contribuciones clave
- Traditionally credited as the principal author of the Sushruta Samhita, one of the foundational Sanskrit texts of Ayurvedic medicine and surgery.
- The Sushruta Samhita contains a dedicated chapter (Jalaukāvacāraṇīya, Sutrasthana 13) on the application of leeches (Sanskrit jalauka), describing indications, leech selection, application technique, and post-application care.
- Distinguished therapeutic (non-venomous) leech species from venomous freshwater leeches, an early taxonomic discrimination relevant to modern medicinal-leech species selection.
- Described leech application as the gentlest of the bloodletting methods, suitable for delicate patients, children, and the elderly when venesection was considered too aggressive.
- His surgical text integrates leech therapy into a broader system that includes plastic and reconstructive procedures for nasal and ear reconstruction, anticipating themes that resurface in modern reconstructive microsurgery contexts where leeches are FDA-cleared.
Importancia para la hirudoterapia
Susruta occupies the foundational position in the Indian textual tradition of medicinal leech application. The Sushruta Samhita, whose extant form is generally dated by scholars to the early centuries of the common era but whose core material is traditionally ascribed to a much earlier teaching lineage, contains the earliest known systematic surgical and procedural discussion of leech therapy in any medical literature. The dedicated chapter on leech application within the Sutrasthana describes the procedure in remarkable practical detail: how to identify suitable therapeutic species, how to keep leeches before use, how to encourage attachment to the patient, how to detach leeches once feeding is complete, and how to manage the patient and the leech afterwards. The Indian tradition's classification of leeches into categories of suitability for medical use — distinguishing therapeutic leeches from those whose bite was considered harmful — represents one of the earliest exercises in what would today be called medical-grade species selection. The same conceptual move would be made again, with modern molecular taxonomy, in the twenty-first century when Siddall and colleagues clarified that the commercial medicinal leech of European pharmacies was largely Hirudo verbana rather than Hirudo medicinalis sensu stricto. The American Society of Hirudotherapy regards the Sushruta tradition as one of the great independent ancient sources of medicinal-leech doctrine, parallel to and largely independent of the Greco-Roman lineage that runs from Hippocrates through Galen and Avicenna. The persistence of jalauka therapy within classical Ayurveda — and its formal recognition by the Government of India's Ministry of AYUSH as a regulated traditional medical procedure — represents a continuous practice tradition extending across more than two thousand years.
Publicaciones clave
- Sushruta Samhita (Suśrutasaṃhitā) · Sanskrit surgical compendium, transmitted via manuscript tradition (-600)
Recursos externos
Investigación influenciada
Compuestos y áreas de investigación que se remontan a las contribuciones de esta figura:
Figuras relacionadas
Iain S. Whitaker
1976- · Británico (galés)
Cirujano reconstructivo galés cuya revisión sistemática de 2012 sobre la terapia con sanguijuelas en el rescate de colgajos microquirúrgicos estableció la base de evidencia moderna para el uso de sanguijuelas después de la reconstrucción con colgajo libre.
Anne-Caroline Herlin
1978- · Francés
Cirujana plástica francesa cuyo artículo de 2017 estableció el régimen de profilaxis de doble agente ahora estándar de ciprofloxacino + trimetoprima-sulfametoxazol para cepas resistentes a Aeromonas durante la terapia con sanguijuelas.
William C. Lineaweaver
1952- · Estadounidense
Microcirujano estadounidense cuyo artículo de 1992 documentó por primera vez la transmisión de Aeromonas hydrophila de las sanguijuelas medicinales a pacientes quirúrgicos — estableciendo el marco de control de infecciones sobre el cual se construyó toda la investigación posterior sobre profilaxis.
Hippocrates of Cos
460-370 BCE · Griego (jónico)
Médico griego tradicionalmente considerado el padre de la medicina occidental, en cuyo Corpus se documenta como práctica clínica rutinaria la aplicación de sanguijuelas para sangrías locales y equilibrio humoral.